- Report
- May 2024
- 137 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1438EUR$1,500USD£1,202GBP
The Hemorrhoids Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Hemorrhoids drugs are used to treat the symptoms of hemorrhoids, which are swollen veins in the rectum and anus. These drugs can be administered orally, topically, or through injection. Commonly used drugs include corticosteroids, anti-inflammatory agents, and vasoconstrictors. These drugs can reduce inflammation, reduce pain, and shrink the size of the hemorrhoid.
Hemorrhoids drugs are available in both prescription and over-the-counter forms. Prescription drugs are typically more effective than over-the-counter drugs, but they can also have more side effects. Over-the-counter drugs are generally safer and more affordable.
Some companies in the Hemorrhoids Drug market include GlaxoSmithKline, Pfizer, Merck, and Johnson & Johnson. Other companies include Bayer, Novartis, and Sanofi. Show Less Read more